AstraZeneca vaccine: Drugmaker hopes the world can focus on its positive news. But experts fear a lack of transparency has clouded that

When the British-Swedish drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine is 70% effective on average, the world exhaled a collective sigh of relief and stocks rallied. Another vaccine with promising results had arrived.